{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:53:04Z","timestamp":1790124784665,"version":"4.0.1"},"reference-count":362,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012905","name":"Shandong Province Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012905","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013058","name":"Jiangsu Provincial Key Research and Development Program","doi-asserted-by":"publisher","award":["BE2022840"],"award-info":[{"award-number":["BE2022840"]}],"id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2025MS1306"],"award-info":[{"award-number":["ZR2025MS1306"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272819"],"award-info":[{"award-number":["82272819"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972888"],"award-info":[{"award-number":["81972888"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong Province","doi-asserted-by":"publisher","award":["2025CXPT176"],"award-info":[{"award-number":["2025CXPT176"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biotechnology Advances"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.biotechadv.2026.108921","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:01:08Z","timestamp":1778889668000},"page":"108921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Re-balancing immunity with CRISPR-Cas9: Novel strategies for cancer and autoimmune disorders"],"prefix":"10.1016","volume":"90","author":[{"given":"Xuanqi","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingkai","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibo","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.biotechadv.2026.108921_bb0005","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa1807315","article-title":"CD47 blockade by Hu5F9-G4 and rituximab in non-Hodgkin's lymphoma","volume":"379","author":"Advani","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.biotechadv.2026.108921_bb0010","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02512-2021","article-title":"The paradox of immune checkpoint inhibition re-activating tuberculosis","volume":"60","author":"Ahmed","year":"2022","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.biotechadv.2026.108921_bb0015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ymeth.2017.03.005","article-title":"Genome editing using CRISPR\/Cas9-based knock-in approaches in zebrafish","volume":"121-122","author":"Albadri","year":"2017","journal-title":"Methods"},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108921_bb0020","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201900367","article-title":"Gene editing enables T-cell engineering to redirect antigen specificity for potent tumor rejection","volume":"2","author":"Albers","year":"2019","journal-title":"Life Sci Alliance"},{"issue":"11","key":"10.1016\/j.biotechadv.2026.108921_bb0025","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41592-020-0966-x","article-title":"An efficient KRAB domain for CRISPRi applications in human cells","volume":"17","author":"Alerasool","year":"2020","journal-title":"Nat. Methods"},{"issue":"3","key":"10.1016\/j.biotechadv.2026.108921_bb0030","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1182\/blood-2011-01-325266","article-title":"Autoimmunity associated with immunotherapy of cancer","volume":"118","author":"Amos","year":"2011","journal-title":"Blood"},{"issue":"7785","key":"10.1016\/j.biotechadv.2026.108921_bb0035","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.biotechadv.2026.108921_bb0040","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.4049\/jimmunol.2100686","article-title":"ERAP1 controls the autoimmune response against melanocytes in psoriasis by generating the melanocyte autoantigen and regulating its amount for HLA-C*06:02 presentation","volume":"207","author":"Arakawa","year":"2021","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108921_bb0045","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/nar\/gkn952","article-title":"Novel mutations in Moloney murine leukemia virus reverse transcriptase increase thermostability through tighter binding to template-primer","volume":"37","author":"Arezi","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biotechadv.2026.108921_bb0050","series-title":"Genetic Editing of CISH Enhances T Cell Effector Programs Independently of Immune Checkpoint Cell Surface Ligand Expression","author":"Arthofer","year":"2021"},{"key":"10.1016\/j.biotechadv.2026.108921_bb0055","first-page":"353","article-title":"Mechanism and applications of CRISPR\/Cas-9-mediated genome editing","volume":"15","author":"Asmamaw","year":"2021","journal-title":"Biologics"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0060","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1101\/gr.161638.113","article-title":"Highly efficient CRISPR\/Cas9-mediated knock-in in zebrafish by homology-independent DNA repair","volume":"24","author":"Auer","year":"2014","journal-title":"Genome Res."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.108921_bb0065","first-page":"337","article-title":"CRISPRi-mediated knock-down of PRDM1\/BLIMP1 programs central memory differentiation in ex vivo-expanded human T cells","volume":"12","author":"Azadbakht","year":"2022","journal-title":"Bioimpacts"},{"issue":"10","key":"10.1016\/j.biotechadv.2026.108921_bb0070","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1002\/bit.25629","article-title":"CRISPR-Cas targeted plasmid integration into mammalian cells via non-homologous end joining","volume":"112","author":"Bachu","year":"2015","journal-title":"Biotechnol. Bioeng."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.108921_bb0075","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.neuron.2018.01.021","article-title":"Multiple sclerosis: mechanisms and immunotherapy","volume":"97","author":"Baecher-Allan","year":"2018","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0080","first-page":"1421","article-title":"Role of the CRISPR system in controlling gene transcription and monitoring cell fate (review)","volume":"17","author":"Baliou","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108921_bb0085","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","article-title":"Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins","volume":"185","author":"Banskota","year":"2022","journal-title":"Cell"},{"issue":"5819","key":"10.1016\/j.biotechadv.2026.108921_bb0090","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1126\/science.1138140","article-title":"CRISPR provides acquired resistance against viruses in prokaryotes","volume":"315","author":"Barrangou","year":"2007","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.biotechadv.2026.108921_bb0095","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004244","article-title":"Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity","volume":"10","author":"Bernard","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0100","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/imr.12464","article-title":"Innate immune mediators in cancer: between defense and resistance","volume":"274","author":"Berraondo","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biotechadv.2026.108921_bb0105","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1182\/blood-2019-129162","article-title":"Primary human NK cell gene-editing reveals a critical role for NKG2A in cytokine-induced memory-like NK cell responses","volume":"134","author":"Berrien-Elliott","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.biotechadv.2026.108921_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108402","article-title":"The role of IL-17 and anti-IL-17 agents in the immunopathogenesis and management of autoimmune and inflammatory diseases","volume":"102","author":"Berry","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"9","key":"10.1016\/j.biotechadv.2026.108921_bb0115","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.tig.2016.06.007","article-title":"Regulation of single-Strand annealing and its role in genome maintenance","volume":"32","author":"Bhargava","year":"2016","journal-title":"Trends Genet."},{"key":"10.1016\/j.biotechadv.2026.108921_bb0120","doi-asserted-by":"crossref","first-page":"1724291","DOI":"10.3389\/fgeed.2025.1724291","article-title":"Therapeutic applications of CRISPR-Cas9 gene editing","volume":"7","author":"Bharti","year":"2025","journal-title":"Front Genome Ed"},{"key":"10.1016\/j.biotechadv.2026.108921_bb0125","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev-genet-110410-132430","article-title":"CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation","volume":"45","author":"Bhaya","year":"2011","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.biotechadv.2026.108921_bb0130","doi-asserted-by":"crossref","first-page":"1063303","DOI":"10.3389\/fimmu.2022.1063303","article-title":"Multiplexed engineering and precision gene editing in cellular immunotherapy","volume":"13","author":"Biederst\u00e4dt","year":"2022","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.biotechadv.2026.108921_bb0135","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1534\/g3.116.030601","article-title":"CRISPR\/Cas9-mediated insertion of loxP sites in the mouse Dock7 gene provides an effective alternative to use of targeted embryonic","volume":"6","author":"Bishop","year":"2016","journal-title":"Stem Cells G3 (Bethesda)"},{"issue":"4","key":"10.1016\/j.biotechadv.2026.108921_bb0140","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1158\/2159-8290.CD-15-0944","article-title":"Suppression of metastases using a new lymphocyte checkpoint target for Cancer immunotherapy","volume":"6","author":"Blake","year":"2016","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2021.11.007","article-title":"Emerging strategies for treating autoimmune disorders with genetically modified Treg cells","volume":"149","author":"Boardman","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"issue":"10","key":"10.1016\/j.biotechadv.2026.108921_bb0150","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1002\/eji.201344388","article-title":"Midline 1 directs lytic granule exocytosis and cytotoxicity of mouse killer T cells","volume":"44","author":"Boding","year":"2014","journal-title":"Eur. J. Immunol."},{"issue":"Pt 8","key":"10.1016\/j.biotechadv.2026.108921_bb0155","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1099\/mic.0.28048-0","article-title":"Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin","volume":"151","author":"Bolotin","year":"2005","journal-title":"Microbiology (Reading)"},{"issue":"7","key":"10.1016\/j.biotechadv.2026.108921_bb0160","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41571-024-00903-0","article-title":"Current understanding and management of CAR T cell-associated toxicities","volume":"21","author":"Brudno","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.biotechadv.2026.108921_bb0165","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.stemcr.2017.03.022","article-title":"Genome engineering of stem cells for autonomously regulated, closed-loop delivery of biologic drugs","volume":"8","author":"Brunger","year":"2017","journal-title":"Stem Cell Rep."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108921_bb0170","first-page":"368","article-title":"CAR-adapted PIK3CD base editing enhances T cell anti-tumor potency","volume":"7","author":"Bucher","year":"2026","journal-title":"Nat. Can."},{"issue":"7670","key":"10.1016\/j.biotechadv.2026.108921_bb0175","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature23643","article-title":"CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity","volume":"549","author":"Burr","year":"2017","journal-title":"Nature"},{"issue":"769","key":"10.1016\/j.biotechadv.2026.108921_bb0180","doi-asserted-by":"crossref","first-page":"eadj6779","DOI":"10.1126\/scitranslmed.adj6779","article-title":"High-fidelity PAMless base editing of hematopoietic stem cells to treat chronic granulomatous disease","volume":"16","author":"Bzhilyanskaya","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0190","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1101\/gr.251561.119","article-title":"A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis","volume":"30","author":"Cai","year":"2020","journal-title":"Genome Res."},{"issue":"19","key":"10.1016\/j.biotechadv.2026.108921_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914865","article-title":"CRISPR\/dCas9 tools: epigenetic mechanism and application in gene transcriptional regulation","volume":"24","author":"Cai","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biotechadv.2026.108921_bb0200","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ymeth.2017.03.008","article-title":"Functional interrogation of non-coding DNA through CRISPR genome editing","volume":"121-122","author":"Canver","year":"2017","journal-title":"Methods"},{"issue":"8003","key":"10.1016\/j.biotechadv.2026.108921_bb0205","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41586-024-07087-8","article-title":"Durable and efficient gene silencing in vivo by hit-and-run epigenome editing","volume":"627","author":"Cappelluti","year":"2024","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.biotechadv.2026.108921_bb0210","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/nri2438","article-title":"Immunotherapy of autoimmunity and cancer: the penalty for success","volume":"8","author":"Caspi","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biotechadv.2026.108921_bb0215","first-page":"75","article-title":"Role of PD-1 in immunity and diseases","volume":"410","author":"Chamoto","year":"2017","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108921_bb0220","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","article-title":"Identification of preexisting adaptive immunity to Cas9 proteins in humans","volume":"25","author":"Charlesworth","year":"2019","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.108921_bb0225","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41576-022-00541-1","article-title":"Prime editing for precise and highly versatile genome manipulation","volume":"24","author":"Chen","year":"2023","journal-title":"Nat. Rev. Genet."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.108921_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1609","article-title":"Strategies for nonviral nanoparticle-based delivery of CRISPR\/Cas9 therapeutics","volume":"12","author":"Chen","year":"2020","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"22","key":"10.1016\/j.biotechadv.2026.108921_bb0235","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.1016\/j.cell.2021.09.018","article-title":"Enhanced prime editing systems by manipulating cellular determinants of editing outcomes","volume":"184","author":"Chen","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0240","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s40164-023-00457-4","article-title":"CRISPR\/Cas9 system: recent applications in immuno-oncology and cancer immunotherapy","volume":"12","author":"Chen","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"issue":"18","key":"10.1016\/j.biotechadv.2026.108921_bb0255","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1016\/j.cell.2023.07.016","article-title":"A membrane-associated MHC-I inhibitory axis for cancer immune evasion","volume":"186","author":"Chen","year":"2023","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.biotechadv.2026.108921_bb0260","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/BOR.0000000000000298","article-title":"Rare variants, autoimmune disease, and arthritis","volume":"28","author":"Chung","year":"2016","journal-title":"Curr. Opin. Rheumatol."},{"issue":"9","key":"10.1016\/j.biotechadv.2026.108921_bb0265","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1101\/gr.246900.118","article-title":"Targeted delivery of CRISPR interference system against Fabp4 to white adipocytes ameliorates obesity, inflammation, hepatic steatosis, and insulin resistance","volume":"29","author":"Chung","year":"2019","journal-title":"Genome Res."},{"issue":"8","key":"10.1016\/j.biotechadv.2026.108921_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103851","article-title":"Autoreactive B cells in autoimmune diseases: mechanisms, functions and clinical implications","volume":"24","author":"Collet","year":"2025","journal-title":"Autoimmun. Rev."},{"issue":"6121","key":"10.1016\/j.biotechadv.2026.108921_bb0275","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"issue":"10391","key":"10.1016\/j.biotechadv.2026.108921_bb0280","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(23)00457-9","article-title":"Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK","volume":"401","author":"Conrad","year":"2023","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.biotechadv.2026.108921_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/cells12050732","article-title":"Host cell restriction factors blocking efficient vector transduction: challenges in lentiviral and adeno-associated vector based gene therapies","volume":"12","author":"Coroadinha","year":"2023","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.biotechadv.2026.108921_bb0290","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00035-19","article-title":"Infectious complications of biological and small molecule targeted immunomodulatory therapies","volume":"33","author":"Davis","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.biotechadv.2026.108921_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2017.10.002","article-title":"Exhaustion of T lymphocytes in the tumor microenvironment: significance and effective mechanisms","volume":"322","author":"Davoodzadeh Gholami","year":"2017","journal-title":"Cell. Immunol."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.108921_bb0300","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1128\/JB.01412-07","article-title":"Phage response to CRISPR-encoded resistance in Streptococcus thermophilus","volume":"190","author":"Deveau","year":"2008","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.biotechadv.2026.108921_bb0305","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.copbio.2016.06.003","article-title":"Transcriptional regulation with CRISPR-Cas9: principles, advances, and applications","volume":"40","author":"Didovyk","year":"2016","journal-title":"Curr. Opin. Biotechnol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0310","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12943-022-01559-z","article-title":"Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing","volume":"21","author":"Dimitri","year":"2022","journal-title":"Mol. Cancer"},{"issue":"46","key":"10.1016\/j.biotechadv.2026.108921_bb0315","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adp9371","article-title":"TET2 regulates early and late transitions in exhausted CD8(+) T cell differentiation and limits CAR T cell function","volume":"10","author":"Dimitri","year":"2024","journal-title":"Sci. Adv."},{"issue":"18","key":"10.1016\/j.biotechadv.2026.108921_bb0320","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1016\/j.cell.2023.07.039","article-title":"Phage-assisted evolution and protein engineering yield compact, efficient prime editors","volume":"186","author":"Doman","year":"2023","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.biotechadv.2026.108921_bb0325","article-title":"CRISPR\/Cas9 systems: delivery technologies and biomedical applications","volume":"18","author":"Du","year":"2023","journal-title":"Asian J Pharm Sci"},{"issue":"4","key":"10.1016\/j.biotechadv.2026.108921_bb0330","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ccell.2025.03.019","article-title":"CAR-T therapy in solid tumors","volume":"43","author":"Du","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biotechadv.2026.108921_bb0335","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/annrheumdis-2018-eular.3946","article-title":"OP0288 transcriptional perturbation of ra-risk enhancer by crispr-deadcas9 regulates long range gene targets","volume":"77","author":"Duffus","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.biotechadv.2026.108921_bb0340","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0345","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-51782-z","article-title":"Enhanced tumor response to adoptive T cell therapy with PHD2\/3-deficient CD8 T cells","volume":"15","author":"Dvorakova","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biotechadv.2026.108921_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115257","article-title":"CRISPR interference-mediated silencing of pro-inflammatory genes in autoimmune models: functional and biophysical evaluation with sustained effects in primary human PBMCs","volume":"163","author":"Eladl","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"7643","key":"10.1016\/j.biotechadv.2026.108921_bb0355","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature21405","article-title":"Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection","volume":"543","author":"Eyquem","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.biotechadv.2026.108921_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123511","article-title":"Nanoparticles-mediated intratumoral gene editing targeting PD-L1 and Galectin-9 for improved cancer immunotherapy","volume":"324","author":"Fang","year":"2026","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.biotechadv.2026.108921_bb0365","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/art.42829","article-title":"A Multilayered Post-Genome-Wide Association Study Analysis Pipeline Defines Functional Variants and Target Genes for Systemic Lupus Erythematosus","volume":"76","author":"Fazel-Najafabadi","year":"2024","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0370","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41467-022-28442-1","article-title":"Prime editing efficiency and fidelity are enhanced in the absence of mismatch repair","volume":"13","author":"Ferreira da Silva","year":"2022","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.biotechadv.2026.108921_bb0375","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41573-019-0041-4","article-title":"Next-generation regulatory T cell therapy","volume":"18","author":"Ferreira","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"13","key":"10.1016\/j.biotechadv.2026.108921_bb0380","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2219956120","article-title":"WDFY4 deficiency in NOD mice ameliorates autoimmune diabetes and insulitis","volume":"120","author":"Ferris","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.biotechadv.2026.108921_bb0385","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1038\/s12276-024-01310-2","article-title":"Immunoliposome-based targeted delivery of the CRISPR\/Cas9gRNA-IL30 complex inhibits prostate cancer and prolongs survival","volume":"56","author":"Fieni","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.108921_bb0390","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3727\/096368916X690863","article-title":"Allele-specific reduction of the mutant huntingtin allele using transcription activator-like effectors in human Huntington's disease fibroblasts","volume":"25","author":"Fink","year":"2016","journal-title":"Cell Transplant."},{"issue":"9","key":"10.1016\/j.biotechadv.2026.108921_bb0395","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/j.celrep.2018.02.014","article-title":"A single administration of CRISPR\/Cas9 lipid nanoparticles achieves robust and persistent in vivo genome editing","volume":"22","author":"Finn","year":"2018","journal-title":"Cell Rep."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.108921_bb0400","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.it.2004.10.001","article-title":"Evolution of innate and adaptive immunity: can we draw a line?","volume":"25","author":"Flajnik","year":"2004","journal-title":"Trends Immunol."},{"issue":"11","key":"10.1016\/j.biotechadv.2026.108921_bb0405","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.4049\/jimmunol.1900485","article-title":"The CD137 ligand is important for type 1 diabetes development but dispensable for the homeostasis of disease-suppressive CD137(+) FOXP3(+) regulatory CD4 T cells","volume":"204","author":"Foda","year":"2020","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108921_bb0410","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/10430340252769770","article-title":"Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors","volume":"13","author":"Follenzi","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.biotechadv.2026.108921_bb0415","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13578-019-0357-0","article-title":"CRISPRa-mediated FOXP3 gene upregulation in mammalian cells","volume":"9","author":"Forstneri\u010d","year":"2019","journal-title":"Cell Biosci."},{"issue":"7709","key":"10.1016\/j.biotechadv.2026.108921_bb0420","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41586-018-0178-z","article-title":"Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells","volume":"558","author":"Fraietta","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0425","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41392-022-00947-7","article-title":"Antibody drug conjugate: the \"biological missile\" for targeted cancer therapy","volume":"7","author":"Fu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0430","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1038\/s41467-025-56735-8","article-title":"Dynamic properties of transcriptional condensates modulate CRISPRa-mediated gene activation","volume":"16","author":"Fu","year":"2025","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.biotechadv.2026.108921_bb0435","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.4049\/jimmunol.1100272","article-title":"Type 1 diabetes-associated IL2RA variation lowers IL-2 signaling and contributes to diminished CD4+CD25+ regulatory T cell function","volume":"188","author":"Garg","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.biotechadv.2026.108921_bb0440","series-title":"The Immunobiology of Cancer: From Tumor Escape to Cancer Immunoediting Towards Immunotherapy in Gynecologic Oncology","author":"Gasparri","year":"2017"},{"issue":"7681","key":"10.1016\/j.biotechadv.2026.108921_bb0445","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of a\u2022T to G\u2022C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.biotechadv.2026.108921_bb0450","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/s41587-020-0491-6","article-title":"Directed evolution of adenine base editors with increased activity and therapeutic application","volume":"38","author":"Gaudelli","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biotechadv.2026.108921_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105834","article-title":"Viral and non-viral vectors in gene therapy: current state and clinical perspectives","volume":"118","author":"Geng","year":"2025","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108921_bb0460","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2013.06.044","article-title":"CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes","volume":"154","author":"Gilbert","year":"2013","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.biotechadv.2026.108921_bb0465","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.biotechadv.2026.108921_bb0470","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/gt.2016.28","article-title":"CRISPR-on system for the activation of the endogenous human INS gene","volume":"23","author":"Gim\u00e9nez","year":"2016","journal-title":"Gene Ther."},{"issue":"8","key":"10.1016\/j.biotechadv.2026.108921_bb0475","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1517\/17425240902932908","article-title":"Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy","volume":"6","author":"Gindy","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108921_bb0480","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.tibtech.2017.11.006","article-title":"Engineering the delivery system for CRISPR-based genome editing","volume":"36","author":"Glass","year":"2018","journal-title":"Trends Biotechnol."},{"issue":"Suppl 2","key":"10.1016\/j.biotechadv.2026.108921_bb0485","article-title":"113 CISH gene-knockout anti-CD70-CAR NK cells demonstrate potent anti-tumor activity against solid tumor cell lines and provide partial resistance to tumor microenvironment inhibition","volume":"9","author":"Guo","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.biotechadv.2026.108921_bb0490","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001975","article-title":"CBLB ablation with CRISPR\/Cas9 enhances cytotoxicity of human placental stem cell-derived NK cells for cancer immunotherapy","volume":"9","author":"Guo","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"12_Supplement","key":"10.1016\/j.biotechadv.2026.108921_bb0495","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1158\/1538-7445.AM2022-5512","article-title":"Abstract 5512: CBLB, CISH and CD70 multiplexed gene knockout with CRISPR\/Cas9 enhances cytotoxicity of CD70-CAR NK cells and provides greater resistance to TGF-\u03b2 for cancer immunotherapy","volume":"82","author":"Guo","year":"2022","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.biotechadv.2026.108921_bb0500","article-title":"In situ extended immune activation instantly after tumor resection by oncolytic virus controls postoperative tumor recurrence","volume":"6","author":"Guo","year":"2025","journal-title":"Cell Rep Med"},{"issue":"11","key":"10.1016\/j.biotechadv.2026.108921_bb0505","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/s41587-023-02085-z","article-title":"In vivo human T cell engineering with enveloped delivery vehicles","volume":"42","author":"Hamilton","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biotechadv.2026.108921_bb0510","article-title":"Programmable conjugative CRISPR interference targeting genotoxin in the gut","author":"Hamp","year":"2025","journal-title":"bioRxiv"},{"issue":"5","key":"10.1016\/j.biotechadv.2026.108921_bb0515","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.biotechadv.2026.108921_bb0520","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.3389\/fimmu.2019.02160","article-title":"Characterization of cxorf21 provides molecular insight into female-Bias immune response in SLE pathogenesis","volume":"10","author":"Harris","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biotechadv.2026.108921_bb0525","doi-asserted-by":"crossref","first-page":"11315","DOI":"10.1038\/srep11315","article-title":"Electroporation enables the efficient mRNA delivery into the mouse zygotes and facilitates CRISPR\/Cas9-based genome editing","volume":"5","author":"Hashimoto","year":"2015","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.biotechadv.2026.108921_bb0530","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgad243","article-title":"Titrating CD47 by mismatch CRISPR-interference reveals incomplete repression can eliminate IgG-opsonized tumors but limits induction of antitumor IgG","volume":"2","author":"Hayes","year":"2023","journal-title":"PNAS Nexus"},{"issue":"9","key":"10.1016\/j.biotechadv.2026.108921_bb0535","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkw064","article-title":"Knock-in of large reporter genes in human cells via CRISPR\/Cas9-induced homology-dependent and independent DNA repair","volume":"44","author":"He","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"17","key":"10.1016\/j.biotechadv.2026.108921_bb0540","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202000208","article-title":"Aptamer\/peptide-functionalized genome-editing system for effective immune restoration through reversal of PD-L1-mediated Cancer immunosuppression","volume":"32","author":"He","year":"2020","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.108921_bb0545","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41423-022-00972-0","article-title":"Dhx33 promotes B-cell growth and proliferation by controlling activation-induced rRNA upregulation","volume":"20","author":"He","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.biotechadv.2026.108921_bb0550","doi-asserted-by":"crossref","first-page":"7129","DOI":"10.1182\/blood-2023-186365","article-title":"Prime editing efficiently and precisely corrects causative mutation in chronic granulomatous disease, restoring myeloid function: toward development of a prime edited autologous hematopoietic stem cell therapy","volume":"142","author":"Heath","year":"2023","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0555","doi-asserted-by":"crossref","first-page":"2005344","DOI":"10.1080\/2162402X.2021.2005344","article-title":"Cancer cells under immune attack acquire CD47-mediated adaptive immune resistance independent of the myeloid CD47-SIRP\u03b1 axis","volume":"10","author":"Hendriks","year":"2021","journal-title":"Oncoimmunology"},{"issue":"13","key":"10.1016\/j.biotechadv.2026.108921_bb0560","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25137171","article-title":"Regulatory T cell dysfunction in autoimmune diseases","volume":"25","author":"Honing","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biotechadv.2026.108921_bb0565","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.18173","article-title":"Replication study: the CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors","volume":"6","author":"Horrigan","year":"2017","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.biotechadv.2026.108921_bb0570","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1128\/JB.01415-07","article-title":"Diversity, activity, and evolution of CRISPR loci in Streptococcus thermophilus","volume":"190","author":"Horvath","year":"2008","journal-title":"J. Bacteriol."},{"issue":"14","key":"10.1016\/j.biotechadv.2026.108921_bb0575","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147393","article-title":"IL-37 targets TSLP-primed basophils to alleviate atopic dermatitis","volume":"22","author":"Hou","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.108921_bb0580","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/art.42390","article-title":"Integrative functional genomics identifies systemic lupus erythematosus causal genetic variant in the IRF5 risk locus","volume":"75","author":"Hou","year":"2023","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.biotechadv.2026.108921_bb0585","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.biotechadv.2026.108921_bb0590","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s13238-020-00690-1","article-title":"Cell-cell contact-induced gene editing\/activation in mammalian cells using a synNotch-CRISPR\/Cas9 system","volume":"11","author":"Huang","year":"2020","journal-title":"Protein Cell"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0595","doi-asserted-by":"crossref","DOI":"10.59717\/j.xinn-med.2024.100050","article-title":"CRISPRa engineered elite macrophages enable adoptive cell therapy for rheumatoid arthritis","volume":"2","author":"Huang","year":"2024","journal-title":"The Innovation Medicine"},{"issue":"10","key":"10.1016\/j.biotechadv.2026.108921_bb0600","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.ymthe.2023.07.016","article-title":"Dual-locus, dual-HDR editing permits efficient generation of antigen-specific regulatory T cells with robust suppressive activity","volume":"31","author":"Hunt","year":"2023","journal-title":"Mol. Ther."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.108921_bb0605","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1128\/jb.169.12.5429-5433.1987","article-title":"Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product","volume":"169","author":"Ishino","year":"1987","journal-title":"J. Bacteriol."},{"issue":"30","key":"10.1016\/j.biotechadv.2026.108921_bb0610","doi-asserted-by":"crossref","first-page":"26267","DOI":"10.1074\/jbc.R111.252569","article-title":"KAP1 protein: an enigmatic master regulator of the genome","volume":"286","author":"Iyengar","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0615","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1158\/2159-8290.CD-22-1319","article-title":"Disruption of SUV39H1-mediated H3K9 methylation sustains CAR T-cell function","volume":"14","author":"Jain","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biotechadv.2026.108921_bb0620","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"Janeway","year":"2002","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108921_bb0625","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1089\/crispr.2018.29014.jas","article-title":"Under the influence: Cas9 ends and DNA repair outcomes","volume":"1","author":"Jasin","year":"2018","journal-title":"Crispr j"},{"issue":"11","key":"10.1016\/j.biotechadv.2026.108921_bb0630","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/s41587-021-00943-2","article-title":"Adenine base editor engineering reduces editing of bystander cytosines","volume":"39","author":"Jeong","year":"2021","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0635","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1038\/s41467-025-58364-7","article-title":"An innovative approach using CRISPR-ribonucleoprotein packaged in virus-like particles to generate genetically engineered mouse models","volume":"16","author":"Jeong","year":"2025","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.biotechadv.2026.108921_bb0640","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.stem.2024.09.003","article-title":"Epitope prime editing shields hematopoietic cells from CD123 immunotherapy for acute myeloid leukemia","volume":"31","author":"Ji","year":"2024","journal-title":"Cell Stem Cell"},{"issue":"15","key":"10.1016\/j.biotechadv.2026.108921_bb0645","doi-asserted-by":"crossref","first-page":"6884","DOI":"10.7150\/ijbs.124144","article-title":"Precision reprogramming in CAR-T cell therapy: innovations, challenges, and future directions of advanced gene editing","volume":"21","author":"Jia","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biotechadv.2026.108921_bb0650","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1146\/annurev-biophys-062215-010822","article-title":"CRISPR-Cas9 structures and mechanisms","volume":"46","author":"Jiang","year":"2017","journal-title":"Annu. Rev. Biophys."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0655","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12943-022-01612-x","article-title":"I-CRISPR: a personalized cancer therapy strategy through cutting cancer-specific mutations","volume":"21","author":"Jiang","year":"2022","journal-title":"Mol. Cancer"},{"issue":"6096","key":"10.1016\/j.biotechadv.2026.108921_bb0660","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.biotechadv.2026.108921_bb0665","doi-asserted-by":"crossref","first-page":"326042","DOI":"10.1155\/2015\/326042","article-title":"CRISPR\/CAS9-mediated genome editing of miRNA-155 inhibits proinflammatory cytokine production by RAW264.7 cells","volume":"2015","author":"Jing","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"16","key":"10.1016\/j.biotechadv.2026.108921_bb0670","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1158\/0008-5472.CAN-18-0030","article-title":"CRISPR\/Cas9-mediated knockout of DGK improves antitumor activities of human T cells","volume":"78","author":"Jung","year":"2018","journal-title":"Cancer Res."},{"issue":"17","key":"10.1016\/j.biotechadv.2026.108921_bb0675","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176240","article-title":"CRISPR-Cas9 DNA Base-editing and prime-editing","volume":"21","author":"Kantor","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.biotechadv.2026.108921_bb0680","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11102764","article-title":"Long-term use of immunosuppressive agents increased the risk of fractures in patients with autoimmune diseases: An 18-year population-based cohort study","volume":"11","author":"Kao","year":"2023","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.biotechadv.2026.108921_bb0685","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf105","article-title":"Packaged delivery of CRISPR-Cas9 ribonucleoproteins accelerates genome editing","volume":"53","author":"Karp","year":"2025","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.biotechadv.2026.108921_bb0690","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41568-022-00441-w","article-title":"CRISPR in cancer biology and therapy","volume":"22","author":"Katti","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.biotechadv.2026.108921_bb0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103816","article-title":"The role of CRISPR-Cas9 and CRISPR interference technologies in the treatment of autoimmune diseases","volume":"24","author":"Khademi","year":"2025","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.biotechadv.2026.108921_bb0700","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jconrel.2017.09.013","article-title":"Cancer-derived exosomes as a delivery platform of CRISPR\/Cas9 confer cancer cell tropism-dependent targeting","volume":"266","author":"Kim","year":"2017","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.biotechadv.2026.108921_bb0705","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cell.2018.05.013","article-title":"Genetic inactivation of CD33 in hematopoietic stem cells to enable CAR T cell immunotherapy for acute myeloid leukemia","volume":"173","author":"Kim","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.biotechadv.2026.108921_bb0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120798","article-title":"A novel therapeutic modality using CRISPR-engineered dendritic cells to treat allergies","volume":"273","author":"Kim","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.biotechadv.2026.108921_bb0715","doi-asserted-by":"crossref","first-page":"1062365","DOI":"10.3389\/fimmu.2023.1062365","article-title":"Reprogramming of IL-12 secretion in the PDCD1 locus improves the anti-tumor activity of NY-ESO-1 TCR-T cells","volume":"14","author":"Kim","year":"2023","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.biotechadv.2026.108921_bb0720","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16091197","article-title":"Advances in nanoparticles as non-viral vectors for efficient delivery of CRISPR\/Cas9","volume":"16","author":"Kim","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biotechadv.2026.108921_bb0725","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.omtn.2018.09.006","article-title":"Transient retrovirus-based CRISPR\/Cas9 all-in-one particles for efficient, targeted gene knockout","volume":"13","author":"Knopp","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"issue":"9","key":"10.1016\/j.biotechadv.2026.108921_bb0730","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nbt.4172","article-title":"Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction","volume":"36","author":"Koblan","year":"2018","journal-title":"Nat. Biotechnol."},{"issue":"7603","key":"10.1016\/j.biotechadv.2026.108921_bb0735","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.biotechadv.2026.108921_bb0740","doi-asserted-by":"crossref","first-page":"eaao4774","DOI":"10.1126\/sciadv.aao4774","article-title":"Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T:A base editors with higher efficiency and product purity","volume":"3","author":"Komor","year":"2017","journal-title":"Sci. Adv."},{"issue":"7536","key":"10.1016\/j.biotechadv.2026.108921_bb0745","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nature14136","article-title":"Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex","volume":"517","author":"Konermann","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0750","article-title":"Thymopentin enhances adenoviral oncolytic therapy by regulating macrophages and CD8(+) T cells","volume":"6","author":"Kong","year":"2026","journal-title":"Commun. Med. (Lond.)."},{"issue":"38","key":"10.1016\/j.biotechadv.2026.108921_bb0755","doi-asserted-by":"crossref","first-page":"10631","DOI":"10.1073\/pnas.1524490113","article-title":"De novo DNA methylation by DNA methyltransferase 3a controls early effector CD8+ T-cell fate decisions following activation","volume":"113","author":"Ladle","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.biotechadv.2026.108921_bb0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109494","article-title":"Optimized CRISPR-mediated gene knockin reveals FOXP3-independent maintenance of human Treg identity","volume":"36","author":"Lam","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.biotechadv.2026.108921_bb0765","series-title":"Personalized CRISPR Knock-In Cytokine Gene Therapy to Remodel the Tumor Microenvironment and Enhance CAR T Cell Therapy in Solid Tumors","author":"Launspach","year":"2025"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2022.106968","article-title":"The landscape of CRISPR\/Cas9 for inborn errors of metabolism","volume":"138","author":"Leal","year":"2023","journal-title":"Mol. Genet. Metab."},{"issue":"11","key":"10.1016\/j.biotechadv.2026.108921_bb0775","doi-asserted-by":"crossref","first-page":"6562","DOI":"10.1093\/nar\/gkac454","article-title":"Binding of the transcription activator-like effector augments transcriptional regulation by another transcription factor","volume":"50","author":"Leben","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.108921_bb0780","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41573-020-00092-2","article-title":"B cell depletion therapies in autoimmune disease: advances and mechanistic insights","volume":"20","author":"Lee","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biotechadv.2026.108921_bb0785","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120793","article-title":"Systemic delivery of CRISPR\/Cas9 to hepatic tumors for cancer treatment using altered tropism of lentiviral vector","volume":"272","author":"Lee","year":"2021","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0790","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.1038\/s41467-022-33669-z","article-title":"Marker-free co-selection for successive rounds of prime editing in human cells","volume":"13","author":"Levesque","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biotechadv.2026.108921_bb0795","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3389\/fphar.2017.00460","article-title":"Drugs for autoimmune inflammatory diseases: from small molecule compounds to anti-TNF biologics","volume":"8","author":"Li","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"6625","key":"10.1016\/j.biotechadv.2026.108921_bb0800","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1126\/science.ade0156","article-title":"Multidimensional control of therapeutic human cell function with synthetic gene circuits","volume":"378","author":"Li","year":"2022","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0805","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13059-022-02618-w","article-title":"A large-scale genome and transcriptome sequencing analysis reveals the mutation landscapes induced by high-activity adenine base editors in plants","volume":"23","author":"Li","year":"2022","journal-title":"Genome Biol."},{"issue":"9","key":"10.1016\/j.biotechadv.2026.108921_bb0810","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24097736","article-title":"Viral vector-based gene therapy","volume":"24","author":"Li","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0815","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-025-01736-9","article-title":"Targeting triple-negative breast cancer using cord-blood CD34+ HSPC-derived mesothelin-specific CAR-NKT cells with potent antitumor activity","volume":"18","author":"Li","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"18","key":"10.1016\/j.biotechadv.2026.108921_bb0820","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.3748\/wjg.v25.i18.2177","article-title":"Harnessing the potential of gene editing technology using CRISPR in inflammatory bowel disease","volume":"25","author":"Limanskiy","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biotechadv.2026.108921_bb0825","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.744823","article-title":"Advances in universal CAR-T cell therapy","volume":"12","author":"Lin","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0830","article-title":"Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation","volume":"14","author":"Lin","year":"2023","journal-title":"Nat. Commun."},{"issue":"37","key":"10.1016\/j.biotechadv.2026.108921_bb0835","doi-asserted-by":"crossref","first-page":"25657","DOI":"10.1021\/acsnano.4c07750","article-title":"Oral microto-Nano genome-editing system enabling targeted delivery and conditional activation of CRISPR-Cas9 for gene therapy of inflammatory bowel disease","volume":"18","author":"Lin","year":"2024","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.biotechadv.2026.108921_bb0840","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41565-024-01851-7","article-title":"Customizable virus-like particles deliver CRISPR-Cas9 ribonucleoprotein for effective ocular neovascular and Huntington's disease gene therapy","volume":"20","author":"Ling","year":"2025","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0845","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1080\/10717544.2018.1474964","article-title":"Delivering CRISPR: a review of the challenges and approaches","volume":"25","author":"Lino","year":"2018","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0850","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/cr.2016.142","article-title":"CRISPR-Cas9-mediated multiplex gene editing in CAR-T cells","volume":"27","author":"Liu","year":"2017","journal-title":"Cell Res."},{"issue":"44","key":"10.1016\/j.biotechadv.2026.108921_bb0855","doi-asserted-by":"crossref","first-page":"6143","DOI":"10.1038\/onc.2017.209","article-title":"Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers","volume":"36","author":"Liu","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.biotechadv.2026.108921_bb0860","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jconrel.2018.10.018","article-title":"Tumor targeted genome editing mediated by a multi-functional gene vector for regulating cell behaviors","volume":"291","author":"Liu","year":"2018","journal-title":"J. Control. Release"},{"issue":"33","key":"10.1016\/j.biotechadv.2026.108921_bb0865","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201902575","article-title":"Fast and efficient CRISPR\/Cas9 genome editing in vivo enabled by bioreducible lipid and messenger RNA nanoparticles","volume":"31","author":"Liu","year":"2019","journal-title":"Adv. Mater."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.108921_bb0870","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/procel\/pwad013","article-title":"CRISPR-assisted transcription activation by phase-separation proteins","volume":"14","author":"Liu","year":"2023","journal-title":"Protein Cell"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0875","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12943-023-01738-6","article-title":"Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy","volume":"22","author":"Liu","year":"2023","journal-title":"Mol. Cancer"},{"issue":"22","key":"10.1016\/j.biotechadv.2026.108921_bb0880","doi-asserted-by":"crossref","first-page":"10500","DOI":"10.1039\/D4NR01408A","article-title":"Advanced micro\/nano-electroporation for gene therapy: recent advances and future outlook","volume":"16","author":"Liu","year":"2024","journal-title":"Nanoscale"},{"issue":"10","key":"10.1016\/j.biotechadv.2026.108921_bb0885","article-title":"Thymosin \u03b11 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacy","volume":"5","author":"Liu","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.biotechadv.2026.108921_bb0890","first-page":"529","article-title":"Novel strategy for tumor immunotherapy using FITC-folate bispecific adapter bridged CAR immune cell cocktails","volume":"52","author":"Liu","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.biotechadv.2026.108921_bb0900","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-med-112311-083918","article-title":"Harnessing the power of the immune system to target cancer","volume":"64","author":"Liz\u00e9e","year":"2013","journal-title":"Annu. Rev. Med."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0905","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1158\/2159-8290.CD-22-1350","article-title":"SUV39H1 ablation enhances long-term CAR T function in solid tumors","volume":"14","author":"L\u00f3pez-Cobo","year":"2024","journal-title":"Cancer Discov."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.108921_bb0910","article-title":"Virus-like particle mediated CRISPR\/Cas9 delivery for efficient and safe genome editing","volume":"10","author":"Lyu","year":"2020","journal-title":"Life (Basel)"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0915","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s40164-025-00654-3","article-title":"Addressing graft-versus-host disease in allogeneic cell-based immunotherapy for cancer","volume":"14","author":"Lyu","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0920","article-title":"TRIM28 promotes the escape of gastric cancer cells from immune surveillance by increasing PD-L1 abundance","volume":"8","author":"Ma","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.biotechadv.2026.108921_bb0925","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41423-024-01148-8","article-title":"Cellular metabolism regulates the differentiation and function of T-cell subsets","volume":"21","author":"Ma","year":"2024","journal-title":"Cell. Mol. Immunol."},{"issue":"10","key":"10.1016\/j.biotechadv.2026.108921_bb0930","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nmeth.2598","article-title":"CRISPR RNA-guided activation of endogenous human genes","volume":"10","author":"Maeder","year":"2013","journal-title":"Nat. Methods"},{"issue":"6","key":"10.1016\/j.biotechadv.2026.108921_bb0935","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrmicro2577","article-title":"Evolution and classification of the CRISPR-Cas systems","volume":"9","author":"Makarova","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"issue":"6121","key":"10.1016\/j.biotechadv.2026.108921_bb0940","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0945","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41467-018-07845-z","article-title":"Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins","volume":"10","author":"Mangeot","year":"2019","journal-title":"Nat. Commun."},{"issue":"7664","key":"10.1016\/j.biotechadv.2026.108921_bb0950","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature23270","article-title":"In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target","volume":"547","author":"Manguso","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biotechadv.2026.108921_bb0955","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1101\/gr.145441.112","article-title":"Obligate ligation-gated recombination (ObLiGaRe): custom-designed nuclease-mediated targeted integration through nonhomologous end joining","volume":"23","author":"Maresca","year":"2013","journal-title":"Genome Res."},{"issue":"9","key":"10.1016\/j.biotechadv.2026.108921_bb0960","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1111\/cas.14993","article-title":"CAR-NK cell in cancer immunotherapy; A promising frontier","volume":"112","author":"Marofi","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biotechadv.2026.108921_bb0965","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115359","article-title":"Delivery of nucleic acid based genome editing platforms via lipid nanoparticles: clinical applications","volume":"211","author":"Masarwy","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108921_bb0970","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212850","article-title":"The Crohn's disease associated SNP rs6651252 impacts MYC gene expression in human colonic epithelial cells","volume":"14","author":"Matthews","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.biotechadv.2026.108921_bb0975","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/bs.pmbts.2020.12.018","article-title":"Rewriting CFTR to cure cystic fibrosis","volume":"182","author":"Maule","year":"2021","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb0980","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.xphs.2019.10.003","article-title":"Immunogenicity of Cas9 protein","volume":"109","author":"Mehta","year":"2020","journal-title":"J. Pharm. Sci."},{"issue":"23","key":"10.1016\/j.biotechadv.2026.108921_bb0985","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia","volume":"384","author":"Meisel","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.108921_bb0990","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1158\/2159-8290.CD-22-1029","article-title":"CD137 (4-1BB)-based Cancer immunotherapy on its 25th anniversary","volume":"13","author":"Melero","year":"2023","journal-title":"Cancer Discov."},{"issue":"9","key":"10.1016\/j.biotechadv.2026.108921_bb0995","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1172\/JCI80009","article-title":"Therapeutic cancer vaccines","volume":"125","author":"Melief","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.biotechadv.2026.108921_bb1000","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","article-title":"The cancer-immunity cycle: indication, genotype, and immunotype","volume":"56","author":"Mellman","year":"2023","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.biotechadv.2026.108921_bb1005","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103505","article-title":"Design of lipid-based nanoparticles for delivery of therapeutic nucleic acids","volume":"28","author":"Mendon\u00e7a","year":"2023","journal-title":"Drug Discov. Today"},{"issue":"8","key":"10.1016\/j.biotechadv.2026.108921_bb1010","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1128\/JVI.74.8.3793-3803.2000","article-title":"Nonrandom transduction of recombinant adeno-associated virus vectors in mouse hepatocytes in vivo: cell cycling does not influence hepatocyte transduction","volume":"74","author":"Miao","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.biotechadv.2026.108921_bb1015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/bs.pmbts.2017.05.003","article-title":"CRISPR\/Cas9-enabled multiplex genome editing and its application","volume":"149","author":"Minkenberg","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1020","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41392-021-00462-1","article-title":"Nanobody-based chimeric antigen receptor T cells designed by CRISPR\/Cas9 technology for solid tumor immunotherapy","volume":"6","author":"Mo","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"7","key":"10.1016\/j.biotechadv.2026.108921_bb1025","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0438-23.2024","article-title":"Cell-Specific Single Viral Vector CRISPR\/Cas9 Editing and Genetically Encoded Tool Delivery in the Central and Peripheral Nervous Systems","volume":"11","author":"Moffa","year":"2024","journal-title":"eNeuro"},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108921_bb1030","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00239-004-0046-3","article-title":"Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements","volume":"60","author":"Mojica","year":"2005","journal-title":"J. Mol. Evol."},{"issue":"24","key":"10.1016\/j.biotechadv.2026.108921_bb1035","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1093\/nar\/24.24.4859","article-title":"Transcriptional repression by RING finger protein TIF1 beta that interacts with the KRAB repressor domain of KOX1","volume":"24","author":"Moosmann","year":"1996","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.biotechadv.2026.108921_bb1040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073489","article-title":"CRISPR-Cas9-mediated TIM3 knockout in human natural killer cells enhances growth inhibitory effects on human glioma cells","volume":"22","author":"Morimoto","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"Supplement_1","key":"10.1016\/j.biotechadv.2026.108921_bb1045","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.208.Supp.56.17","article-title":"CRISPRi and KO screens reveal integrated cis- and trans-regulation of the CD28, CTLA4, and ICOS locus in primary human T cells","volume":"208","author":"Mowery","year":"2022","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.biotechadv.2026.108921_bb1050","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004446","article-title":"Production and characterization of virus-free, CRISPR-CAR T cells capable of inducing solid tumor regression","volume":"10","author":"Mueller","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"110","key":"10.1016\/j.biotechadv.2026.108921_bb1055","doi-asserted-by":"crossref","first-page":"eadr3838","DOI":"10.1126\/sciimmunol.adr3838","article-title":"Human CD4(+) T cells regulate peripheral immune responses in rheumatoid arthritis via insulin-like growth factor-like family member 2","volume":"10","author":"Murakami","year":"2025","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.biotechadv.2026.108921_bb1060","doi-asserted-by":"crossref","first-page":"5560","DOI":"10.1038\/ncomms6560","article-title":"Microhomology-mediated end-joining-dependent integration of donor DNA in cells and animals using TALENs and CRISPR\/Cas9","volume":"5","author":"Nakade","year":"2014","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.108921_bb1065","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","article-title":"Adeno-associated virus (AAV) as a vector for gene therapy","volume":"31","author":"Naso","year":"2017","journal-title":"BioDrugs"},{"issue":"26","key":"10.1016\/j.biotechadv.2026.108921_bb1070","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene Ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.108921_bb1075","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41587-021-01039-7","article-title":"Engineered pegRNAs improve prime editing efficiency","volume":"40","author":"Nelson","year":"2022","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1080","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1038\/s41467-022-31504-z","article-title":"CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas","volume":"13","author":"Niborski","year":"2022","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.108921_bb1085","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1042\/EBC20160017","article-title":"The immune system","volume":"60","author":"Nicholson","year":"2016","journal-title":"Essays Biochem."},{"issue":"6305","key":"10.1016\/j.biotechadv.2026.108921_bb1090","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf8729","article-title":"Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems","volume":"353","author":"Nishida","year":"2016","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.biotechadv.2026.108921_bb1095","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061704","article-title":"CRISPR-mediated non-viral site-specific gene integration and expression in T cells: protocol and application for T-cell therapy","volume":"12","author":"Od\u00e9","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"7662","key":"10.1016\/j.biotechadv.2026.108921_bb1100","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.biotechadv.2026.108921_bb1105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/intimm\/dxy006","article-title":"Generation of tumor antigen-specific murine CD8+ T cells with enhanced anti-tumor activity via highly efficient CRISPR\/Cas9 genome editing","volume":"30","author":"Ouchi","year":"2018","journal-title":"Int. Immunol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1110","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.1038\/s41467-024-50794-z","article-title":"A genetic-epigenetic interplay at 1q21.1 locus underlies CHD1L-mediated vulnerability to primary progressive multiple sclerosis","volume":"15","author":"Pahlevan Kakhki","year":"2024","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.108921_bb1115","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"7669","key":"10.1016\/j.biotechadv.2026.108921_bb1120","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature23477","article-title":"Identification of essential genes for cancer immunotherapy","volume":"548","author":"Patel","year":"2017","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.biotechadv.2026.108921_bb1125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26199452","article-title":"Advances and applications of Plant Base editing technologies","volume":"26","author":"Peng","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.biotechadv.2026.108921_bb1130","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nmeth.2600","article-title":"RNA-guided gene activation by CRISPR-Cas9-based transcription factors","volume":"10","author":"Perez-Pinera","year":"2013","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1135","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jaci.2016.04.025","article-title":"Identification of a subset of human natural killer cells expressing high levels of programmed death 1: a phenotypic and functional characterization","volume":"139","author":"Pesce","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.108921_bb1140","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41571-025-01072-4","article-title":"Next-generation T cell immunotherapies engineered with CRISPR base and prime editing: challenges and opportunities","volume":"22","author":"Petri","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.biotechadv.2026.108921_bb1145","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41581-023-00720-1","article-title":"Pathogenesis of autoimmune disease","volume":"19","author":"Pisetsky","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1150","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ymthe.2019.10.009","article-title":"A genetically engineered primary human natural killer cell platform for Cancer immunotherapy","volume":"28","author":"Pomeroy","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biotechadv.2026.108921_bb1155","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev-pharmtox-010814-124454","article-title":"Genome editing: a new approach to human therapeutics","volume":"56","author":"Porteus","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"Pt 3","key":"10.1016\/j.biotechadv.2026.108921_bb1160","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1099\/mic.0.27437-0","article-title":"CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies","volume":"151","author":"Pourcel","year":"2005","journal-title":"Microbiology (Reading)"},{"issue":"620","key":"10.1016\/j.biotechadv.2026.108921_bb1165","doi-asserted-by":"crossref","first-page":"eabh0272","DOI":"10.1126\/scitranslmed.abh0272","article-title":"Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity","volume":"13","author":"Prinzing","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.biotechadv.2026.108921_bb1170","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.cell.2013.02.022","article-title":"Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression","volume":"152","author":"Qi","year":"2013","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.biotechadv.2026.108921_bb1175","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.7150\/thno.107908","article-title":"Supercharging CAR-T cells through transcriptional and epigenetic armoring","volume":"15","author":"Qin","year":"2025","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1180","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54292-0","article-title":"In vivo gene editing of T-cells in lymph nodes for enhanced cancer immunotherapy","volume":"15","author":"Qu","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26010314","article-title":"Defining mechanistic links between the non-coding variant rs17673553 in CLEC16A and lupus susceptibility","volume":"26","author":"Rallabandi","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108921_bb1190","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/gb-2013-14-2-107","article-title":"A CRISPR way to engineer the human genome","volume":"14","author":"Ramalingam","year":"2013","journal-title":"Genome Biol."},{"issue":"7","key":"10.1016\/j.biotechadv.2026.108921_bb1195","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41573-024-00959-8","article-title":"Sequential immunotherapy: towards cures for autoimmunity","volume":"23","author":"Ram\u00edrez-Valle","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1200","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-43790-2","article-title":"Leukemia-intrinsic determinants of CAR-T response revealed by iterative in vivo genome-wide CRISPR screening","volume":"14","author":"Ramos","year":"2023","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.biotechadv.2026.108921_bb1205","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.4049\/jimmunol.1700024","article-title":"Genetic and small molecule disruption of the AID\/RAD51 Axis similarly protects nonobese diabetic mice from type 1 diabetes through expansion of regulatory B lymphocytes","volume":"198","author":"Ratiu","year":"2017","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.biotechadv.2026.108921_bb1210","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s41587-020-0453-z","article-title":"Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity","volume":"38","author":"Richter","year":"2020","journal-title":"Nat. Biotechnol."},{"issue":"7714","key":"10.1016\/j.biotechadv.2026.108921_bb1215","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-018-0326-5","article-title":"Reprogramming human T cell function and specificity with non-viral genome targeting","volume":"559","author":"Roth","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.biotechadv.2026.108921_bb1220","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.jid.2020.03.230","article-title":"225 Desmoglein 1 deficiency in knockout mice impairs epidermal barrier formation and results in a psoriasis-like gene signature in E18.5 embryos","volume":"140","author":"Roth-Carter","year":"2020","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108921_bb1225","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cell.2016.09.011","article-title":"Engineering T cells with customized therapeutic response programs using synthetic notch receptors","volume":"167","author":"Roybal","year":"2016","journal-title":"Cell"},{"issue":"1\u20132","key":"10.1016\/j.biotechadv.2026.108921_bb1230","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cell.2018.11.022","article-title":"Coupled single-cell CRISPR screening and epigenomic profiling reveals causal gene regulatory networks","volume":"176","author":"Rubin","year":"2019","journal-title":"Cell"},{"issue":"3 Pt 1","key":"10.1016\/j.biotechadv.2026.108921_bb1235","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.fertnstert.2023.02.040","article-title":"The history, use, and challenges of therapeutic somatic cell and germline gene editing","volume":"120","author":"Ryu","year":"2023","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1240","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nprot.2015.140","article-title":"MMEJ-assisted gene knock-in using TALENs and CRISPR-Cas9 with the PITCh systems","volume":"11","author":"Sakuma","year":"2016","journal-title":"Nat. Protoc."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108921_bb1245","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1139\/bcb-2016-0137","article-title":"Precision genome editing in the CRISPR era","volume":"95","author":"Salsman","year":"2017","journal-title":"Biochem. Cell Biol."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.108921_bb1250","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/sj.gt.3302170","article-title":"Lentiviral vectors pseudotyped with baculovirus gp64 efficiently transduce mouse cells in vivo and show tropism restriction against hematopoietic cell types in vitro","volume":"11","author":"Schauber","year":"2004","journal-title":"Gene Ther."},{"issue":"48","key":"10.1016\/j.biotechadv.2026.108921_bb1255","doi-asserted-by":"crossref","first-page":"eadc9657","DOI":"10.1126\/sciadv.adc9657","article-title":"Phosphofructokinase P fine-tunes T regulatory cell metabolism, function, and stability in systemic autoimmunity","volume":"8","author":"Scherlinger","year":"2022","journal-title":"Sci. Adv."},{"issue":"6580","key":"10.1016\/j.biotechadv.2026.108921_bb1260","doi-asserted-by":"crossref","first-page":"eabj4008","DOI":"10.1126\/science.abj4008","article-title":"CRISPR activation and interference screens decode stimulation responses in primary human T cells","volume":"375","author":"Schmidt","year":"2022","journal-title":"Science"},{"issue":"6024","key":"10.1016\/j.biotechadv.2026.108921_bb1265","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"issue":"33","key":"10.1016\/j.biotechadv.2026.108921_bb1270","doi-asserted-by":"crossref","first-page":"10437","DOI":"10.1073\/pnas.1512503112","article-title":"Generation of knock-in primary human T cells using Cas9 ribonucleoproteins","volume":"112","author":"Schumann","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.biotechadv.2026.108921_bb1275","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.stem.2013.11.002","article-title":"Functional repair of CFTR by CRISPR\/Cas9 in intestinal stem cell organoids of cystic fibrosis patients","volume":"13","author":"Schwank","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"9","key":"10.1016\/j.biotechadv.2026.108921_bb1280","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26094420","article-title":"CRISPR\/Cas9 delivery systems to enhance gene editing efficiency","volume":"26","author":"Seijas","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108921_bb1285","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.bbrc.2017.03.076","article-title":"Transcriptional activation of the MICA gene with an engineered CRISPR-Cas9 system","volume":"486","author":"Sekiba","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1290","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12943-022-01565-1","article-title":"CRISPR\/Cas9 and next generation sequencing in the personalized treatment of Cancer","volume":"21","author":"Selvakumar","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biotechadv.2026.108921_bb1295","first-page":"81","article-title":"Microhomology-mediated end joining: good, bad and ugly","volume":"809","author":"Seol","year":"2018","journal-title":"Mutat. Res."},{"issue":"33","key":"10.1016\/j.biotechadv.2026.108921_bb1300","doi-asserted-by":"crossref","first-page":"16489","DOI":"10.1073\/pnas.1900079116","article-title":"SLAMF9 regulates pDC homeostasis and function in health and disease","volume":"116","author":"Sever","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.biotechadv.2026.108921_bb1305","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.tibs.2015.08.006","article-title":"Microhomology-mediated end joining: a Back-up survival mechanism or dedicated pathway?","volume":"40","author":"Sfeir","year":"2015","journal-title":"Trends Biochem. Sci."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108921_bb1310","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201966","article-title":"TCR signal strength defines distinct mechanisms of T cell dysfunction and cancer evasion","volume":"219","author":"Shakiba","year":"2022","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.108921_bb1315","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.ymthe.2025.01.024","article-title":"Virus-free CRISPR knockin of a chimeric antigen receptor into KLRC1 generates potent GD2-specific natural killer cells","volume":"33","author":"Shankar","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biotechadv.2026.108921_bb1320","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jconrel.2023.12.022","article-title":"Site-specific controlled-release nanoparticles for immune reprogramming via dual metabolic inhibition against triple-negative breast cancer","volume":"366","author":"She","year":"2024","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1325","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13045-019-0831-5","article-title":"Targeting glycosylation of PD-1 to enhance CAR-T cell cytotoxicity","volume":"12","author":"Shi","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"10290","key":"10.1016\/j.biotechadv.2026.108921_bb1330","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.biotechadv.2026.108921_bb1335","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1146\/annurev-immunol-042718-041522","article-title":"CRISPR-based tools in immunity","volume":"37","author":"Simeonov","year":"2019","journal-title":"Annu. Rev. Immunol."},{"issue":"7670","key":"10.1016\/j.biotechadv.2026.108921_bb1340","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature23875","article-title":"Discovery of stimulation-responsive immune enhancers with CRISPR activation","volume":"549","author":"Simeonov","year":"2017","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.biotechadv.2026.108921_bb1345","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1007\/s13346-023-01320-z","article-title":"Recent advances in the delivery and applications of nonviral CRISPR\/Cas9 gene editing","volume":"13","author":"Sinclair","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.108921_bb1350","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrclinonc.2015.209","article-title":"Combination cancer immunotherapies tailored to the tumour microenvironment","volume":"13","author":"Smyth","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108921_bb1355","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40259-026-00767-z","article-title":"Advances in engineered virus-like particles for genome editing and therapy","volume":"40","author":"Son","year":"2026","journal-title":"BioDrugs"},{"key":"10.1016\/j.biotechadv.2026.108921_bb1360","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.2147\/DDDT.S165440","article-title":"Current development of biodegradable polymeric materials for biomedical applications","volume":"12","author":"Song","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1365","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41551-024-01233-3","article-title":"Systematic optimization of prime editing for the efficient functional correction of CFTR F508del in human airway epithelial cells","volume":"9","author":"Sousa","year":"2025","journal-title":"Nat. Biomed. Eng."},{"issue":"6481","key":"10.1016\/j.biotechadv.2026.108921_bb1370","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba7365","article-title":"CRISPR-engineered T cells in patients with refractory cancer","volume":"367","author":"Stadtmauer","year":"2020","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108921_bb1375","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.mayocpiqo.2019.12.006","article-title":"A graduate-level interdisciplinary curriculum in CAR-T cell therapy","volume":"4","author":"Sterner","year":"2020","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"issue":"36","key":"10.1016\/j.biotechadv.2026.108921_bb1380","doi-asserted-by":"crossref","first-page":"eaau9657","DOI":"10.1126\/sciimmunol.aau9657","article-title":"Interleukin-17 receptor D constitutes an alternative receptor for interleukin-17A important in psoriasis-like skin inflammation","volume":"4","author":"Su","year":"2019","journal-title":"Sci. Immunol."},{"issue":"14","key":"10.1016\/j.biotechadv.2026.108921_bb1385","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1128\/MCB.20.14.5300-5309.2000","article-title":"DNA length dependence of the single-strand annealing pathway and the role of Saccharomyces cerevisiae RAD59 in double-strand break repair","volume":"20","author":"Sugawara","year":"2000","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1390","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00018-019-03365-1","article-title":"Structural basis of homologous recombination","volume":"77","author":"Sun","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1395","article-title":"Immunogenic nanovesicle-tandem-augmented chemoimmunotherapy via efficient Cancer-homing delivery and optimized ordinal-interval regime","volume":"10","author":"Sun","year":"2022","journal-title":"Adv Sci (Weinh)"},{"issue":"6","key":"10.1016\/j.biotechadv.2026.108921_bb1400","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2310821121","article-title":"Targeted demethylation and activation of NLRC5 augment cancer immunogenicity through MHC class I","volume":"121","author":"Sun","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7631","key":"10.1016\/j.biotechadv.2026.108921_bb1405","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nature20565","article-title":"In vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration","volume":"540","author":"Suzuki","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.biotechadv.2026.108921_bb1410","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/art.43046","article-title":"FoxO1 deficiency in monocytic myeloid-derived suppressor cells exacerbates B cell dysfunction in systemic lupus erythematosus","volume":"77","author":"Tan","year":"2025","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.108921_bb1415","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2014.09.039","article-title":"A protein-tagging system for signal amplification in gene expression and fluorescence imaging","volume":"159","author":"Tanenbaum","year":"2014","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.biotechadv.2026.108921_bb1420","article-title":"Reprogramming the tumor microenvironment through second-near-infrared-window photothermal genome editing of PD-L1 mediated by supramolecular gold nanorods for enhanced Cancer immunotherapy","volume":"33","author":"Tang","year":"2021","journal-title":"Adv. Mater."},{"issue":"6","key":"10.1016\/j.biotechadv.2026.108921_bb1425","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011716","article-title":"Targeting annexin A2 to reactivate tumor-associated antigens presentation and relieve immune tolerance in liver cancer","volume":"13","author":"Tang","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1430","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1038\/s41467-022-31322-3","article-title":"Frequency and mechanisms of LINE-1 retrotransposon insertions at CRISPR\/Cas9 sites","volume":"13","author":"Tao","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1435","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41467-023-35886-6","article-title":"Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing","volume":"14","author":"Tao","year":"2023","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.biotechadv.2026.108921_bb1440","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1300662","article-title":"Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV","volume":"370","author":"Tebas","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.biotechadv.2026.108921_bb1445","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1016\/j.ymthe.2022.06.006","article-title":"Universal allogeneic CAR T cells engineered with sleeping beauty transposons and CRISPR-CAS9 for cancer immunotherapy","volume":"30","author":"Tipanee","year":"2022","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1450","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-35583-w","article-title":"Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy","volume":"14","author":"Trefny","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biotechadv.2026.108921_bb1455","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.toxrep.2018.10.001","article-title":"The dose response principle from philosophy to modern toxicology: the impact of ancient philosophy and medicine in modern toxicology science","volume":"5","author":"Tsatsakis","year":"2018","journal-title":"Toxicol. Rep."},{"issue":"10","key":"10.1016\/j.biotechadv.2026.108921_bb1460","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s41589-019-0342-2","article-title":"CRISPR-Cas9 screens identify regulators of antibody-drug conjugate toxicity","volume":"15","author":"Tsui","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"16","key":"10.1016\/j.biotechadv.2026.108921_bb1465","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1182\/blood-2017-07-796342","article-title":"Immune evasion via PD-1\/PD-L1 on NK cells and monocyte\/macrophages is more prominent in Hodgkin lymphoma than DLBCL","volume":"131","author":"Vari","year":"2018","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.biotechadv.2026.108921_bb1470","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.ymthe.2019.07.002","article-title":"Targeted activation of cystic fibrosis transmembrane conductance regulator","volume":"27","author":"Villamizar","year":"2019","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.108921_bb1475","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cell.2019.06.014","article-title":"Augmenting immunotherapy impact by lowering tumor TNF cytotoxicity threshold","volume":"178","author":"Vredevoogd","year":"2019","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.biotechadv.2026.108921_bb1480","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41587-024-02235-x","article-title":"Mapping variant effects on anti-tumor hallmarks of primary human T cells with base-editing screens","volume":"43","author":"Walsh","year":"2025","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108921_bb1485","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2165\/00003495-200060020-00002","article-title":"Viral vectors for gene transfer: a review of their use in the treatment of human diseases","volume":"60","author":"Walther","year":"2000","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.biotechadv.2026.108921_bb1490","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10565-019-09475-7","article-title":"Off-target genome editing: a new discipline of gene science and a new class of medicine","volume":"35","author":"Wang","year":"2019","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.biotechadv.2026.108921_bb1495","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.2147\/OTT.S105862","article-title":"PD-L1 expression in human cancers and its association with clinical outcomes","volume":"9","author":"Wang","year":"2016","journal-title":"Onco. Targets Ther."},{"issue":"15","key":"10.1016\/j.biotechadv.2026.108921_bb1500","doi-asserted-by":"crossref","first-page":"9874","DOI":"10.1021\/acs.chemrev.6b00799","article-title":"CRISPR\/Cas9-based genome editing for disease modeling and therapy: challenges and opportunities for nonviral delivery","volume":"117","author":"Wang","year":"2017","journal-title":"Chem. Rev."},{"issue":"11","key":"10.1016\/j.biotechadv.2026.108921_bb1505","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/s41590-019-0500-4","article-title":"Multiplexed activation of endogenous genes by CRISPRa elicits potent antitumor immunity","volume":"20","author":"Wang","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biotechadv.2026.108921_bb1510","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ebiom.2019.01.045","article-title":"Tumor cells induce LAMP2a expression in tumor-associated macrophage for cancer progression","volume":"40","author":"Wang","year":"2019","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.biotechadv.2026.108921_bb1515","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/1744-7917.12634","article-title":"Programmable activation of Bombyx gene expression using CRISPR\/dCas9 fusion systems","volume":"26","author":"Wang","year":"2019","journal-title":"Insect Sci"},{"key":"10.1016\/j.biotechadv.2026.108921_bb1525","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.canlet.2019.11.033","article-title":"CAR-NK for tumor immunotherapy: clinical transformation and future prospects","volume":"472","author":"Wang","year":"2020","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.biotechadv.2026.108921_bb1530","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaa1264","article-title":"Microbial single-strand annealing proteins enable CRISPR gene-editing tools with improved knock-in efficiencies and reduced off-target effects","volume":"49","author":"Wang","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1535","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12943-022-01518-8","article-title":"Current applications and future perspective of CRISPR\/Cas9 gene editing in cancer","volume":"21","author":"Wang","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1540","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41421-023-00552-0","article-title":"High-efficiency targeted transgene integration via primed micro-homologues","volume":"9","author":"Wang","year":"2023","journal-title":"Cell Discov."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.108921_bb1545","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.it.2024.01.009","article-title":"Targeting MHC-I inhibitory pathways for cancer immunotherapy","volume":"45","author":"Wang","year":"2024","journal-title":"Trends Immunol."},{"issue":"18","key":"10.1016\/j.biotechadv.2026.108921_bb1550","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1016\/j.cell.2024.06.027","article-title":"Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis","volume":"187","author":"Wang","year":"2024","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.biotechadv.2026.108921_bb1555","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009560","article-title":"Precision enhancement of CAR-NK cells through non-viral engineering and highly multiplexed base editing","volume":"13","author":"Wang","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.biotechadv.2026.108921_bb1560","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/s41418-024-01437-9","article-title":"SENP3 inhibition suppresses hepatocellular carcinoma progression and improves the efficacy of anti-PD-1 immunotherapy","volume":"32","author":"Wang","year":"2025","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1565","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13046-025-03358-y","article-title":"Viral expression of NE\/PPE enhances anti-colorectal cancer efficacy of oncolytic adenovirus by promoting TAM M1 polarization to reverse insufficient effector memory\/effector CD8(+) T cell infiltration","volume":"44","author":"Wang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.biotechadv.2026.108921_bb1570","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00439-006-0165-6","article-title":"Treatment of human disease by adeno-associated viral gene transfer","volume":"119","author":"Warrington","year":"2006","journal-title":"Hum. Genet."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1575","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1038\/s41467-019-13007-6","article-title":"Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors","volume":"10","author":"Webber","year":"2019","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.108921_bb1580","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.7150\/thno.87130","article-title":"Midline-1 regulates effector T cell motility in experimental autoimmune encephalomyelitis via mTOR\/microtubule pathway","volume":"14","author":"Wei","year":"2024","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.biotechadv.2026.108921_bb1585","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nbt.3805","article-title":"Large-scale design of robust genetic circuits with multiple inputs and outputs for mammalian cells","volume":"35","author":"Weinberg","year":"2017","journal-title":"Nat. Biotechnol."},{"issue":"714","key":"10.1016\/j.biotechadv.2026.108921_bb1590","doi-asserted-by":"crossref","first-page":"eadi1145","DOI":"10.1126\/scitranslmed.adi1145","article-title":"Epitope base editing CD45 in hematopoietic cells enables universal blood cancer immune therapy","volume":"15","author":"Wellhausen","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.108921_bb1595","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.cell.2018.12.012","article-title":"Environmental control of astrocyte pathogenic activities in CNS inflammation","volume":"176","author":"Wheeler","year":"2019","journal-title":"Cell"},{"issue":"7796","key":"10.1016\/j.biotechadv.2026.108921_bb1600","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41586-020-1999-0","article-title":"MAFG-driven astrocytes promote CNS inflammation","volume":"578","author":"Wheeler","year":"2020","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.biotechadv.2026.108921_bb1605","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cell.2015.12.035","article-title":"Biology and applications of CRISPR systems: harnessing nature's toolbox for genome engineering","volume":"164","author":"Wright","year":"2016","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.biotechadv.2026.108921_bb1610","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.stem.2013.10.016","article-title":"Correction of a genetic disease in mouse via use of CRISPR-Cas9","volume":"13","author":"Wu","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"11","key":"10.1016\/j.biotechadv.2026.108921_bb1615","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.7150\/thno.74989","article-title":"UBR5 promotes tumor immune evasion through enhancing IFN-\u03b3-induced PDL1 transcription in triple negative breast cancer","volume":"12","author":"Wu","year":"2022","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.biotechadv.2026.108921_bb1620","article-title":"Silk-gel powered adenoviral vector enables robust genome editing of PD-L1 to augment immunotherapy across multiple tumor models","volume":"10","author":"Wu","year":"2023","journal-title":"Adv Sci (Weinh)"},{"issue":"Suppl. 1","key":"10.1016\/j.biotechadv.2026.108921_bb1625","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1634\/theoncologist.2019-IO-S1-s05","article-title":"PD-1\/PD-L1 blockade therapy in advanced non-small-cell lung Cancer: current status and future directions","volume":"24","author":"Xia","year":"2019","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1630","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/s13046-019-1410-x","article-title":"Graphene oxide arms oncolytic measles virus for improved effectiveness of cancer therapy","volume":"38","author":"Xia","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.biotechadv.2026.108921_bb1635","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/cac2.12579","article-title":"\"Find me\" and \"eat me\" signals: tools to drive phagocytic processes for modulating antitumor immunity","volume":"44","author":"Xiao","year":"2024","journal-title":"Cancer Commun. (Lond.)"},{"issue":"4","key":"10.1016\/j.biotechadv.2026.108921_bb1640","doi-asserted-by":"crossref","DOI":"10.1002\/mog2.55","article-title":"Viral vector-based cancer treatment and current clinical applications","volume":"2","author":"Xie","year":"2023","journal-title":"MedComm \u2013 Oncology"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1645","doi-asserted-by":"crossref","first-page":"7948","DOI":"10.1038\/s41467-025-63167-x","article-title":"Programmable epigenome editing by transient delivery of CRISPR epigenome editor ribonucleoproteins","volume":"16","author":"Xu","year":"2025","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.108921_bb1650","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/cas.13958","article-title":"Programmed cell death ligand 1 disruption by clustered regularly interspaced short palindromic repeats\/Cas9-genome editing promotes antitumor immunity and suppresses ovarian cancer progression","volume":"110","author":"Yahata","year":"2019","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.108921_bb1655","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00412-018-0677-6","article-title":"Making ends meet: targeted integration of DNA fragments by genome editing","volume":"127","author":"Yamamoto","year":"2018","journal-title":"Chromosoma"},{"issue":"8008","key":"10.1016\/j.biotechadv.2026.108921_bb1660","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41586-024-07259-6","article-title":"Improving prime editing with an endogenous small RNA-binding protein","volume":"628","author":"Yan","year":"2024","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.biotechadv.2026.108921_bb1665","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1172\/JCI83871","article-title":"Cancer immunotherapy: harnessing the immune system to battle cancer","volume":"125","author":"Yang","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biotechadv.2026.108921_bb1670","article-title":"CRISPR\/Cas: advances, limitations, and applications for precision Cancer research","volume":"8","author":"Yang","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1675","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1186\/s12967-021-03132-6","article-title":"Contextual reprogramming of CAR-T cells for treatment of HER2(+) cancers","volume":"19","author":"Yang","year":"2021","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1680","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12967-023-04014-9","article-title":"Nanoscale, antigen encounter-dependent, IL-12 delivery by CAR T cells plus PD-L1 blockade for cancer treatment","volume":"21","author":"Yang","year":"2023","journal-title":"J. Transl. Med."},{"issue":"9","key":"10.1016\/j.biotechadv.2026.108921_bb1685","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011893","article-title":"LTO1 and YAE1 regulate MHC-I expression via nonsense-mediated RNA decay in tumor cells","volume":"13","author":"Yang","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1690","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2024.11.015","article-title":"Clinical advances of mRNA vaccines for cancer immunotherapy","volume":"6","author":"Yaremenko","year":"2025","journal-title":"Med"},{"issue":"13","key":"10.1016\/j.biotechadv.2026.108921_bb1695","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/smll.200900126","article-title":"Cytotoxicity and immunological response of gold and silver nanoparticles of different sizes","volume":"5","author":"Yen","year":"2009","journal-title":"Small"},{"issue":"8","key":"10.1016\/j.biotechadv.2026.108921_bb1700","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41592-018-0048-5","article-title":"An enhanced CRISPR repressor for targeted mammalian gene regulation","volume":"15","author":"Yeo","year":"2018","journal-title":"Nat. Methods"},{"issue":"7685","key":"10.1016\/j.biotechadv.2026.108921_bb1705","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nature25144","article-title":"Effector CD8 T cells dedifferentiate into long-lived memory cells","volume":"552","author":"Youngblood","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1710","doi-asserted-by":"crossref","first-page":"7903","DOI":"10.1038\/s41467-022-35580-z","article-title":"Design of a self-driven probiotic-CRISPR\/Cas9 nanosystem for sono-immunometabolic cancer therapy","volume":"13","author":"Yu","year":"2022","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.biotechadv.2026.108921_bb1715","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41568-025-00820-z","article-title":"Recent advances in therapeutic cancer vaccines","volume":"25","author":"Zaidi","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108921_bb1720","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.immuni.2011.07.010","article-title":"CD8(+) T cells: foot soldiers of the immune system","volume":"35","author":"Zhang","year":"2011","journal-title":"Immunity"},{"issue":"36","key":"10.1016\/j.biotechadv.2026.108921_bb1725","article-title":"Insights into the mechanisms of immune-checkpoint inhibitors gained from spatiotemporal dynamics of the tumor microenvironment","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.biotechadv.2026.108921_bb1730","doi-asserted-by":"crossref","first-page":"7338","DOI":"10.1038\/srep07338","article-title":"A multicolor panel of TALE-KRAB based transcriptional repressor vectors enabling knockdown of multiple gene targets","volume":"4","author":"Zhang","year":"2014","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.biotechadv.2026.108921_bb1735","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41590-018-0132-0","article-title":"Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity","volume":"19","author":"Zhang","year":"2018","journal-title":"Nat. Immunol."},{"issue":"47","key":"10.1016\/j.biotechadv.2026.108921_bb1740","doi-asserted-by":"crossref","first-page":"20895","DOI":"10.1002\/anie.202009890","article-title":"Optical control of a CRISPR\/Cas9 system for gene editing by using photolabile crRNA","volume":"59","author":"Zhang","year":"2020","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.biotechadv.2026.108921_bb1745","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.574007","article-title":"Extracellular vesicles-mimetic encapsulation improves oncolytic Viro-immunotherapy in tumors with low coxsackie and adenovirus receptor","volume":"8","author":"Zhang","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.biotechadv.2026.108921_bb1750","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105873","article-title":"hIgDFc-Ig inhibits B cell function by regulating the BCR-Syk-Btk-NF-\u03baB signalling pathway in mice with collagen-induced arthritis","volume":"173","author":"Zhang","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.biotechadv.2026.108921_bb1755","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.ymthe.2024.03.028","article-title":"Restoring T and B cell generation in X-linked severe combined immunodeficiency mice through hematopoietic stem cells adenine base editing","volume":"32","author":"Zhang","year":"2024","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.108921_bb1760","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.ymthe.2024.02.008","article-title":"Hitchhiking of Cas9 with nucleus-localized proteins impairs its controllability and leads to efficient genome editing of NLS-free Cas9","volume":"32","author":"Zhang","year":"2024","journal-title":"Mol. Ther."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.108921_bb1765","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1038\/s41401-025-01574-y","article-title":"Peptide-MHC I regulatory mechanisms and intervention strategies in anti-tumor T cell immunity","volume":"46","author":"Zhang","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"issue":"7\u20138","key":"10.1016\/j.biotechadv.2026.108921_bb1770","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00335-010-9275-5","article-title":"A 1-bp deletion in the gammaC-crystallin leads to dominant cataracts in mice","volume":"21","author":"Zhao","year":"2010","journal-title":"Mamm. Genome"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1775","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13045-018-0677-2","article-title":"Universal CARs, universal T cells, and universal CAR T cells","volume":"11","author":"Zhao","year":"2018","journal-title":"J. Hematol. Oncol."},{"issue":"14","key":"10.1016\/j.biotechadv.2026.108921_bb1780","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202208059","article-title":"X-ray-guided in situ genetic engineering of macrophages for sustained Cancer immunotherapy","volume":"35","author":"Zhao","year":"2023","journal-title":"Adv. Mater."},{"issue":"5","key":"10.1016\/j.biotechadv.2026.108921_bb1785","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1007\/s10565-022-09723-3","article-title":"Reactive oxygen signaling molecule inducible regulation of CRISPR-Cas9 gene editing","volume":"39","author":"Zhao","year":"2023","journal-title":"Cell Biol. Toxicol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1790","article-title":"Bacterial protoplast-derived nanovesicles carrying CRISPR-Cas9 tools re-educate tumor-associated macrophages for enhanced cancer immunotherapy","volume":"15","author":"Zhao","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1795","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1158\/1078-0432.CCR-19-1351","article-title":"Targeting EZH2 enhances antigen presentation, antitumor immunity, and circumvents anti\u2013PD-1 resistance in head and neck Cancer","volume":"26","author":"Zhou","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1800","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1038\/s41467-024-46654-5","article-title":"Targeting pathogenic CD8(+) tissue-resident T cells with chimeric antigen receptor therapy in murine autoimmune cholangitis","volume":"15","author":"Zhu","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1805","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1002\/mco2.203","article-title":"Hypoxia signaling in cancer: implications for therapeutic interventions","volume":"4","author":"Zhuang","year":"2023","journal-title":"MedComm"},{"issue":"10","key":"10.1016\/j.biotechadv.2026.108921_bb1810","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri1936","article-title":"Cancer despite immunosurveillance: immunoselection and immunosubversion","volume":"6","author":"Zitvogel","year":"2006","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.biotechadv.2026.108921_bb1815","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/s41587-022-01254-w","article-title":"An engineered prime editor with enhanced editing efficiency in plants","volume":"40","author":"Zong","year":"2022","journal-title":"Nat. Biotechnol."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.108921_bb1820","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrc1586","article-title":"Immunosuppressive networks in the tumour environment and their therapeutic relevance","volume":"5","author":"Zou","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1825","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-025-03182-8","article-title":"Targeting GDF15 to enhance immunotherapy efficacy in glioblastoma through tumor microenvironment-responsive CRISPR-Cas9 nanoparticles","volume":"23","author":"Zou","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108921_bb1830","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41392-025-02269-w","article-title":"CAR-T cell therapy for cancer: current challenges and future directions","volume":"10","author":"Zugasti","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biotechadv.2026.108921_bb1835","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103240","article-title":"Enhanced antitumor efficacy of a novel oncolytic vaccinia virus encoding a fully monoclonal antibody against T-cell immunoglobulin and ITIM domain (TIGIT)","volume":"64","author":"Zuo","year":"2021","journal-title":"EBioMedicine"}],"container-title":["Biotechnology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975026001278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975026001278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T08:02:35Z","timestamp":1784534555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0734975026001278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":362,"alternative-id":["S0734975026001278"],"URL":"https:\/\/doi.org\/10.1016\/j.biotechadv.2026.108921","relation":{},"ISSN":["0734-9750"],"issn-type":[{"value":"0734-9750","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Re-balancing immunity with CRISPR-Cas9: Novel strategies for cancer and autoimmune disorders","name":"articletitle","label":"Article Title"},{"value":"Biotechnology Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biotechadv.2026.108921","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108921"}}